Comparison of the vascular responses to balloon-expandable stenting in the coronary and peripheral circulations: Long-term results in an animal model using the TriMaxx stent

Journal of Vascular Surgery

Volumn 45, Issue 4, 2007, Pages 821-827

  Dubé, Harman ^a   Clifford, Anton G ^a   Barry, Chris M ^a   Schwarten, Donald E ^a   Schwartz, Lewis B ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; PHOSPHORYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BALLOON; BLOOD FLOW; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY STENT; EXPERIMENTAL STUDY; FEMORAL ARTERY; IMPLANTATION; MORPHOMETRICS; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RESTENOSIS; STATISTICAL SIGNIFICANCE; SWINE;

ANGIOPLASTY, BALLOON; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; COATED MATERIALS, BIOCOMPATIBLE; CONSTRICTION, PATHOLOGIC; CORONARY STENOSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; FEMORAL ARTERY; HYPERPLASIA; PHOSPHORYLCHOLINE; PROSTHESIS DESIGN; STENTS; SWINE; TIME FACTORS; VASCULAR PATENCY;

EID: 33947634109     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2006.12.012     Document Type: Article

References (31)

1. Murray C.J., and Lopez A.D. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349 (1997) 1269-1276
2. Dotter C.T., and Judkins M.P. Transluminal trement of arteriosclerotic obstructions. Circ 30 (1964) 654-670
3. Grüntzig A.R., Senning Å., and Siegenthaler W.E. Nonoperative dilatation of coronary artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 301 (1979) 61-68
4. Grüntzig A., and Hopff H. Percutaneous recanalization after chronic arterial occlusion with a new dilator-catheter (modification of the Dotter technique). Dtsch Med Wochenschr 99 (1974) 2502-2510
5. Sigwart U., Puel J., Mirkovitch V., Joffre F., and Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316 (1987) 701-706
6. Sousa J.E., Costa M.A., Abizaid A., Abizaid A.S., Feres F., Pinto I.M.F., et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circ 103 (2001) 192-195
7. Sousa J.E., Costa M.A., Abizaid A.C., Rensing B.J., Abizaid A.S., Tanajura L.F., et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circ 104 (2001) 2007-2011
8. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
9. Windecker S., Remondino A., Eberli F.R., Jüni P., Räber L., Wenaweser P., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005) 653-662
10. Morice M.-C., Colombo A., Meier B., Serruys P., Tamburino C., Guagliumi G., et al., RTI. Sirolimus- vs Paclitaxel-Eluting Stents in De Novo Coronary Artery Lesions: the REALITY trial: a randomized controlled trial. JAMA 295 (2006) 895-904
11. Ring E.J., McLean G.K., and Freiman D.B. Selected techniques in percutaneous transluminal angioplasty. Am J Roentgenol 139 (1982) 767-773
12. Palmaz J.C., Sibbitt R.R., Reuter S.R., Tio F.O., and Rice W.J. Expandable intraluminal graft: a preliminary study. Work in progress. Radiology 156 (1985) 73-77
13. Günther R.W., Vorwerk D., Antonucci F., Beyssen B., Essinger A., Gaux J.C., et al. Iliac artery stenosis or obstruction after unsuccessful balloon angioplasty: treatment with a self-expandable stent. Am J Roentgenol 156 (1991) 389-393
14. Pentecost M.J., Criqui M.H., Dorros G., Goldstone J., Johnston K.W., Martin E.C., et al. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels: a statement for health professionals from a special writing group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association. J Vasc Interv Radiol 14 (2003) S495-S515
15. Costanza M.J., Queral L.A., Lilly M.P., and Finn W.R. Hemodynamic outcome of endovascular therapy for TransAtlantic Inter Society Consensus type B femoropopliteal arterial occlusive lesions. J Vasc Surg 39 (2004) 343-350
16. BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 (2005) 1925-1934
17. Ouriel K. Peripheral arterial disease. Lancet 358 (2001) 1257-1264
18. Gray B.H., Sullivan T.M., Childs M.B., Young J.R., and Olin J.W. High incidence of restenosis/reocclusion of intravascular stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 25 (1997) 74-83
19. Gray B., and Olin J. Limitations of percutaneous transluminal angioplasty with stenting for femoropopliteal arterial occlusive disease. Sem Vasc Surg 10 (1997) 8-16
20. Surowiec S.M., Davies M.D., Eberly S.W., Rhodes J.M., Illig K.A., Shortell C.K., et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 41 (2005) 269-278
21. Schillinger M., Sabeti S., Loewe C., Petra D., Jasmin A., Wolfgang M., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
22. Scheinert D., Scheinert S., Sax J., Piorkowski C., Bräunlich S., Ulrich M., et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45 (2005) 312-315
23. Schlager O., Petra D., Schila S., Jasmin A., Wolfgang M., Erich M., et al. Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 12 (2005) 676-684
24. Schwartz R.S., Murphy J.G., Edwards W.D., Camrud A.R., Vlietstra R.E., and Holmes D.R. Restenosis after balloon angioplasty: a practical proliferative model in porcine coronary arteries. Circ 82 (1990) 2190-2200
25. Schwartz R.S., Edelman E.R., Carter A.C., Chronos N., Rogers C., et al. Drug-eluting stents in preclinical studies: Recommended evaluation from a Consensus Group. Circ 106 (2002) 1867-1873
26. Serruys P.W., Kutryk M.J.B., and Ong A.T.L. Coronary artery stents. N Engl J Med 354 (2006) 483-495
27. Schwartz L.B., Purut C.M., Craig D.M., Smith P.K., and McCann R.L. Input impedance of revascularized skeletal muscle, renal, and mesenteric vascular beds. Vasc Surg 30 (1996) 459-470
28. Smouse H.B., Nikanorov A., and LaFlash D. Biomechanical forces in the femoropopliteal arterial segment. Endovasc Today (2005) 60-66 June
29. Barth K.H., Virmani R., Froelich J., Takeda T., Lossef S.V., Newsome J., et al. Paired comparison of vascular wall reactions to Palmaz stents, Strecker tantalum stents, and Wallstents in canine iliac and femoral arteries. Circ 93 (1996) 2161-2169
30. Nikanorov A., Eckert R., and LaFlash D. Evaluation of the porcine femoral artery during hip/knee flexion before and after placement of nitinol stents (2005), Cardiovascular and Interventional Radiological Society of Europe
31. Kimura T., Yokoi H., Nakagawa Y., Tamura T., Kaburagi S., Sawada Y., et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 334 (1996) 561-566